• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Differences in clinical and angiographic profiles between Asian and Western patients with coronary artery disease: insights from the prospective "real world" paclitaxel-coated balloon registry.

作者信息

Ong Paul Jau Lueng, Zeymer U, Waliszewski M, Tan Julian, Ho Hee Hwa

机构信息

Department of Cardiology, Tan Tock Seng Hospital, Singapore, Singapore.

Klinikum Ludwigshafen, Germany.

出版信息

Int J Cardiol. 2014 Jul 15;175(1):199-200. doi: 10.1016/j.ijcard.2014.04.239. Epub 2014 Apr 28.

DOI:10.1016/j.ijcard.2014.04.239
PMID:24820752
Abstract
摘要

相似文献

1
Differences in clinical and angiographic profiles between Asian and Western patients with coronary artery disease: insights from the prospective "real world" paclitaxel-coated balloon registry.
Int J Cardiol. 2014 Jul 15;175(1):199-200. doi: 10.1016/j.ijcard.2014.04.239. Epub 2014 Apr 28.
2
Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: results from a single-center allcomers registry.西罗莫司洗脱支架与紫杉醇洗脱支架治疗老年冠心病患者的比较：来自单中心所有患者注册研究的结果
Heart Vessels. 2012 Nov;27(6):553-8. doi: 10.1007/s00380-011-0194-5. Epub 2011 Oct 12.
3
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).XIENCE V 依维莫司洗脱冠状动脉支架系统治疗多支冠状动脉疾病患者的临床和血管造影研究：EXECUTIVE 试验（EXecutive RCT：评估 XIENCE V 在多支血管疾病中的应用）。
JACC Cardiovasc Interv. 2013 Oct;6(10):1012-22. doi: 10.1016/j.jcin.2013.05.016. Epub 2013 Sep 18.
4
Analysis of the effect of paclitaxel-eluting stents and paclitaxel-eluting balloon in the treatment of in-stent restenosis.紫杉醇洗脱支架与紫杉醇洗脱球囊治疗支架内再狭窄的效果分析
Pak J Pharm Sci. 2017 Jul;30(4(Suppl.)):1521-1524.
5
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.紫杉醇涂层球囊导管与紫杉醇涂层支架治疗冠状动脉支架内再狭窄：PEPCAD II ISR研究的三年结果
EuroIntervention. 2015 Dec;11(8):926-34. doi: 10.4244/EIJY14M08_12.
6
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates.在不确定药物洗脱支架候选人群中，血管造影冠状动脉疾病复杂性对缺血和出血风险的影响，以及佐他莫司洗脱支架与裸金属支架的比较效果。
Int J Cardiol. 2019 Feb 15;277:60-65. doi: 10.1016/j.ijcard.2018.09.120. Epub 2018 Oct 2.
7
A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels.一项关于紫杉醇涂层球囊与依维莫司洗脱支架治疗小冠状动脉血管的倾向评分匹配比较研究。
Catheter Cardiovasc Interv. 2017 Sep 1;90(3):380-386. doi: 10.1002/ccd.26929. Epub 2017 Jan 21.
8
Comparison of the efficacy and safety of paclitaxel-eluting coroflex please stents and paclitaxel-eluting stents in patients with coronary artery disease: a randomized PIPA trial.比较载紫杉醇可扩张冠状动脉雷帕霉素洗脱支架和紫杉醇洗脱支架治疗冠心病患者的疗效和安全性：一项随机 PIPA 试验。
Catheter Cardiovasc Interv. 2012 Nov 1;80(5):799-806. doi: 10.1002/ccd.23440. Epub 2012 Mar 14.
9
Twelve-month angiographic and clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold and a metallic stent in patients with coronary artery disease.XINSORB 生物可吸收西罗莫司洗脱支架与金属支架治疗冠状动脉疾病患者 12 个月的血管造影和临床结果。
Int J Cardiol. 2019 Oct 15;293:61-66. doi: 10.1016/j.ijcard.2019.06.053. Epub 2019 Jun 20.
10
Clinical and angiographic outcomes of paclitaxel-eluting coronary stent implantation in hemodialysis patients: A prospective multicenter registry: The OUCH-TL study (outcome in hemodialysis of TAXUS Liberte).血液透析患者中紫杉醇洗脱冠状动脉支架植入术的临床及血管造影结果：一项前瞻性多中心注册研究：OUCH-TL研究（TAXUS Liberte在血液透析中的结果）
J Cardiol. 2015 Dec;66(6):502-8. doi: 10.1016/j.jjcc.2015.03.008. Epub 2015 Apr 4.

引用本文的文献

1
Efficacy and safety of drug-coated balloons in the treatment of coronary lesions in very small vessels: a prospective, multicenter, single-arm trial.药物涂层球囊治疗极细血管冠状动脉病变的疗效与安全性：一项前瞻性、多中心、单臂试验。
Ann Transl Med. 2022 Apr;10(8):445. doi: 10.21037/atm-22-1266.
2
Drug-coated balloon treatment in coronary artery disease: Recommendations from an Asia-Pacific Consensus Group.药物涂层球囊治疗冠状动脉疾病：亚太共识小组的建议。
Cardiol J. 2021;28(1):136-149. doi: 10.5603/CJ.a2019.0093. Epub 2019 Sep 30.
3
Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review.
单纯药物涂层球囊经皮冠状动脉介入治疗初发冠状动脉疾病的系统评价
Cardiol Ther. 2018 Dec;7(2):127-149. doi: 10.1007/s40119-018-0121-2. Epub 2018 Oct 27.
4
Drug-Eluting Balloons in the Treatment of Coronary De Novo Lesions: A Comprehensive Review.药物洗脱球囊治疗冠状动脉初发病变：一项综述
Cardiol Ther. 2016 Dec;5(2):133-160. doi: 10.1007/s40119-016-0064-4. Epub 2016 Jul 6.